Vimarsana
Biggest News Aggregation in the World

Page 21 - Cell Lines News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Lines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Lines Today - Breaking & Trending Today

Stem Cell/Cord Blood Banking Market Driven By Increasing Number Of Cancer Patients - Vimarsana News

Stem Cell/Cord Blood Banking Market Driven By Increasing Number Of Cancer Patients

Stem Cell/Cord Blood Banking Global Market Report 2021: COVID-19 Growth And Change To 2030 The Business Research Company’s Stem Cell/Cord Blood Banking Global Market Report 2021: COVID-19 Growth And Change To 2030 LONDON, GREATER LONDON, UK, April 19, 2021 /EINPresswire.com/ -- Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports Increasing number of cancer patients is a major driver for the stem cell and global cord blood market. Cancer diseases such as leukemia a...

"Single-Cell Analysis of BRAF sup V600E /sup and NRAS sup Q61R /sup M" by Joseph W. Po, Yafeng Ma et al. - Vimarsana News

"Single-Cell Analysis of BRAF sup V600E /sup and NRAS sup Q61R /sup M" by Joseph W. Po, Yafeng Ma et al.

Abstract Molecular testing of tumor biopsies allows for the identification of the key mutations driving a patient’s cancer. However, this is limited to singular nodes and may not accurately reflect cancer heterogeneity. Circulating tumor cell (CTC) analyses offer a noninvasive method of interrogating the genomic profile of patient-derived tumor material. To date, molecular analysis of CTCs has relied on the characterization of bulk or pooled CTC lysates, limiting the detection of minor tumorigenic CTC subclones. Here, we show a workflow enabling BRAF /NRAS mutation detection from single cu...

Source: uow.edu.au
Oxidative Stress Assay Market worth $1326 million by 2025 - Exclusive Report by MarketsandMarkets™ - Vimarsana News

Oxidative Stress Assay Market worth $1326 million by 2025 - Exclusive Report by MarketsandMarkets™

The growth of this market is mainly driven by growth in the biopharmaceutical industry and increasing public-sector funding for academic research. Other important factors aiding the growth of this market include technological advancements like HCS for drug discovery, increasing R&D expenditure in biotechnology and pharmaceutical industries, and government support for pharmaceutical and biotechnology industries. On the other hand, the high cost of instruments and shortage of trained and qualified personnel are the major factors restraining the growth of this market. The consumables segment acc...

Oxidative Stress Assay Market worth $1326 million by 2025 - Exclusive Report by MarketsandMarkets - Vimarsana News

Oxidative Stress Assay Market worth $1326 million by 2025 - Exclusive Report by MarketsandMarkets

Oxidative Stress Assay Market worth $1326 million by 2025 - Exclusive Report by MarketsandMarkets "Oxidative Stress Assay Market by Product (Consumable, Instruments, Kits, Services), Test Type (Indirect, nucleic acid, Glutathione, ROS), Technology (ELISA, Chromatography), Diseases (CVD, Oncology) End Users (Pharma & Biotech) - Global Forecasts to 2025", published by MarketsandMarkets, the Oxidative Stress Assay Market is projected to reach USD 1326 million by 2025 from USD 836 million in 2020, at a CAGR of 9.7%. Browse in-depth TOC on Download PDF Brochure: https://www.marketsandmarkets.com...

New Therapy for Parasitic Disease may Help Fight Coronavirus - Vimarsana News

New Therapy for Parasitic Disease may Help Fight Coronavirus

New Therapy for Parasitic Disease may Help Fight Coronavirus by Angela Mohan on  April 5, 2021 at 8:26 PM SARS-CoV-2, the coronavirus that causes COVID-19, can't dock on and infect human cells unless a human enzyme called cathepsin L cleaves the virus' spike protein. Trypanosoma cruzi, the parasite that produce an enzyme called cruzain, helps them to replicate in humans. McKerrow's research team started looking for inhibitors of cruzain. One particularly effective cruzain inhibitor is called K777. They later found that cathepsin L looks and acts like cruzain. In a study pub...